focus -WSS

focus

author：focus 2025-10-01 00:16:57 - browse：79664

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for Duchenne muscular dystrophy. Regulators restricted the treatment to younger patients, with additional data required to broaden its use.

The gene therapy, called Elevydis, is made by Sarepta Therapeutics. The company will charge $3.2 million for the treatment, making it the U.S.’s second most expensive drug, behind a recently approved gene therapy for hemophilia. CEO Doug Ingram said on a conference call the price was below what a recently published company-funded analysis found would be cost-effective.

“The approval of Elevidys is a watershed moment for the treatment of Duchenne. Elevydis is the first and only gene therapy approved for Duchenne, and this approval brings us closer to our goal of bringing forward a treatment that provides the potential to alter the trajectory of this degenerative disease,” Ingram said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Roche to buy Carmot Therapeutics, developer of obesity drugs

WSS

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

The simple reason for the increase in autism diagnosis

Congenital heart disease patients face new threat of heart failure

STAT letters to the editor on burnt

explore

focus

knowledge

Jerome Adams on the need for new antivirals for Covid

Patients' immediate access to test results puts radiologists in a bind

As demand for Covid shots wanes, Moderna seeks its next success

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Psychedelics group wrestles with new pharma identity

Tuskegee Airman Raymond Cassagnol dies at 102

Medicare proposal to cover medical devices draws a mixed reaction

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Supreme Court strikes down use of affirmative action

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

explore

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Radiology is caught between AI's potential and concern for patients

GOP inquiry over gain

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

AI models in health care face new federal disclosure requirements

After sickle

entertainment

Wikipedia

knowledge

explore